Brief: Arrowhead Pharmaceuticals Says Ken Myszkowski To Retire As CFO
15/04/2025 20:51
April 15 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O: ARROWHEAD PHARMACEUTICALS INC - KEN MYSZKOWSKI TO RETIRE AS CFO OF ARROWHEAD PHARMACEUTICALS - SEC FILING ARROWHEAD PHARMACEUTICALS INC - DANIEL APEL APPOINTED AS CFO OF ARROWHEAD PHARMACEUTICALS - SEC FILING Source text: [ID:n0001628280-25-017844] Further company coverage: ARWR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arrowhead Pharmaceuticals
See all newsBrief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers